 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
I-Mab
IMAB
|
94.1 |
- |
- |
$ 866 M |
China |
 |
Midatech Pharma plc
MTP
|
137 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
AIkido Pharma
AIKI
|
0.935 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
38.5 K |
- |
-19.68 % |
$ 18.4 M |
Canada |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Aptorum Group Limited
APM
|
105 |
$ 0.9 |
-2.33 % |
$ 6.62 M |
China |
 |
Genfit SA
GNFT
|
1.96 K |
- |
2.54 % |
$ 160 B |
France |
 |
ACADIA Pharmaceuticals
ACAD
|
3.33 |
$ 21.96 |
-0.68 % |
$ 3.64 B |
USA |
 |
RedHill Biopharma Ltd.
RDHL
|
14 |
$ 1.02 |
-0.49 % |
$ 428 M |
Israel |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Advaxis
ADXS
|
144 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Ampio Pharmaceuticals
AMPE
|
106 |
- |
-11.43 % |
$ 502 K |
USA |
 |
Aligos Therapeutics
ALGS
|
30.2 |
$ 6.4 |
4.4 % |
$ 63.3 M |
USA |
 |
Applied Therapeutics
APLT
|
54.1 |
- |
- |
$ 8.42 M |
USA |
 |
Aptinyx
APTX
|
204 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Aridis Pharmaceuticals
ARDS
|
1.34 |
- |
17.91 % |
$ 11.1 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.73 |
$ 21.41 |
1.9 % |
$ 1 B |
USA |
 |
Aravive
ARAV
|
6.61 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
AstraZeneca PLC
AZN
|
2.17 |
- |
- |
$ 96.9 B |
Britain |
 |
BioDelivery Sciences International
BDSI
|
1.85 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Aeterna Zentaris
AEZS
|
7.87 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Kazia Therapeutics Limited
KZIA
|
21.9 |
$ 12.26 |
3.72 % |
$ 1.62 B |
Australia |
 |
AgeX Therapeutics
AGE
|
0.099 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
BioNTech SE
BNTX
|
35.7 |
$ 105.46 |
-0.09 % |
$ 27.2 B |
Germany |
 |
BeiGene, Ltd.
BGNE
|
66.4 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 |
- |
- |
$ 7.46 M |
Israel |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 |
- |
- |
$ 26.5 M |
USA |
 |
Aquestive Therapeutics
AQST
|
10.5 |
$ 4.08 |
0.25 % |
$ 436 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
9.15 |
$ 23.26 |
1.75 % |
$ 2.96 B |
USA |
 |
Cara Therapeutics
CARA
|
2.58 |
- |
-3.03 % |
$ 260 M |
USA |
 |
Autolus Therapeutics plc
AUTL
|
4.27 |
$ 1.44 |
-5.88 % |
$ 383 M |
Britain |
 |
BioXcel Therapeutics
BTAI
|
24 |
$ 1.06 |
-3.64 % |
$ 12.9 M |
USA |
 |
CASI Pharmaceuticals
CASI
|
36.1 |
- |
- |
$ 35.4 M |
USA |
 |
Cabaletta Bio
CABA
|
50.3 M |
$ 2.95 |
-3.28 % |
$ 296 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
759 |
$ 2.91 |
-1.36 % |
$ 4.79 M |
Israel |
 |
bluebird bio
BLUE
|
2.27 |
- |
- |
$ 546 M |
USA |
 |
CymaBay Therapeutics
CBAY
|
110 |
- |
- |
$ 3.45 B |
USA |